MedPath

Sentinel lymph node mapping and ultrastaging in patients with early stage cervical cancer

Phase 1
Conditions
Early stage cervical cancer (stage IA2-IIA)
Early stage cervical cancer, sentinel lymph node, ultastaging
Registration Number
TCTR20210314002
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
Female
Target Recruitment
23
Inclusion Criteria

1.Early stage cervical cancer (stage IA2-IIA) patients, who detect cervical cancer lesion size less than 4 cm underwent surgery in Siriraj hospital.
2.The surgical process are include open laparotomy and laparoscopic surgery.
3.No previous treatment (radiotherapy, chemotherapy)
4.No underwent pelvic and paraaortic Lymph node Surgery.
5.No contraindication for indocyanine green (iodine sensitivity , hepatic impairment)

Exclusion Criteria

1.Patient can't be able to underwent SLN surgery., 2. pregnancy women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Detection rate of sentinel LN 2 years Frozen section and ultrastaging
Secondary Outcome Measures
NameTimeMethod
Compared Sentinel LN dectection rate between Frozen section and ultrastaging , False negative rate, sensitivity, evaluation factors 2 years Frozen section and ultrastaging
© Copyright 2025. All Rights Reserved by MedPath